Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012588007> ?p ?o ?g. }
- W2012588007 endingPage "23" @default.
- W2012588007 startingPage "16" @default.
- W2012588007 abstract "The therapeutics of obsessive-compulsive disorder (OCD) involves the serotonergic system in the brain; the selective serotonin reuptake inhibitors (SSRIs) are the only class of drugs to be consistently effective for this disorder. Preclinical studies in the orbito-frontal cortex - a brain area known to be involved in mediation of OCD symptoms - show that sustained administration of SSRI for 2 months leads to enhanced 5-HT release. Initially, raised 5-HT levels, resulting from serotonin (5-HT) reuptake inhibition, over-activates the cell body 5-HT1A autoreceptor, which has an inhibitory effect on the neuronal firing rate. However, after long-term administration of SSRIs, these 5-HT1A autoreceptors become desensitized to the raised extracellular 5-HT levels, and increase 5-HT transmission. The recovery of neuronal firing rate is faster with escitalopram (the active S-enantiomer of citalopram) than with citalopram, which may be due to different mechanisms of action. The 5-HT system has reciprocal interactions with the noradrenaline (NA) system. Although not a major mediator in the treatment of OCD symptomatology, patients with anxiety disorders such as panic disorder have increased NA reactivity and/or tone. Long-term SSRI administration reduces the firing rate of NA neurones, unlike 5-HT neurones. Evidence indicates that accrued 5-HT levels have an inhibitory modulatory effect on NA transmission, thus indicating the clinical relevance of SSRI treatment for anxiety disorders. The different effectiveness of the SSRIs escitalopram and citalopram in enhancing synaptic 5-HT levels may be due to the inhibitory action of the R-enantiomer in racemic citalopram on S-enantiomer binding to the 5-HT transporter. This allows escitalopram to produce higher extracellular 5-HT levels than can be achieved by the equivalent S-enantiomer dose of citalopram. Escitalopram is therefore a viable front-line treatment option for people with anxiety disorders, and possibly for those who have failed to respond to conventional SSRI therapies." @default.
- W2012588007 created "2016-06-24" @default.
- W2012588007 creator A5002538047 @default.
- W2012588007 creator A5014960520 @default.
- W2012588007 date "2007-01-01" @default.
- W2012588007 modified "2023-10-18" @default.
- W2012588007 title "The importance of serotonin and noradrenaline in anxiety" @default.
- W2012588007 cites W1970404912 @default.
- W2012588007 cites W1970498796 @default.
- W2012588007 cites W1984167102 @default.
- W2012588007 cites W1991750812 @default.
- W2012588007 cites W1995487101 @default.
- W2012588007 cites W2013832113 @default.
- W2012588007 cites W2014001501 @default.
- W2012588007 cites W2038989561 @default.
- W2012588007 cites W2044359142 @default.
- W2012588007 cites W2061850641 @default.
- W2012588007 cites W2065749995 @default.
- W2012588007 cites W2082363592 @default.
- W2012588007 cites W2083724376 @default.
- W2012588007 cites W2090074630 @default.
- W2012588007 cites W2092756373 @default.
- W2012588007 cites W2122237296 @default.
- W2012588007 cites W2126867924 @default.
- W2012588007 cites W2146162140 @default.
- W2012588007 cites W2167693963 @default.
- W2012588007 cites W4253863377 @default.
- W2012588007 doi "https://doi.org/10.1080/13651500701388310" @default.
- W2012588007 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24926868" @default.
- W2012588007 hasPublicationYear "2007" @default.
- W2012588007 type Work @default.
- W2012588007 sameAs 2012588007 @default.
- W2012588007 citedByCount "13" @default.
- W2012588007 countsByYear W20125880072013 @default.
- W2012588007 countsByYear W20125880072017 @default.
- W2012588007 countsByYear W20125880072019 @default.
- W2012588007 countsByYear W20125880072020 @default.
- W2012588007 countsByYear W20125880072021 @default.
- W2012588007 countsByYear W20125880072023 @default.
- W2012588007 crossrefType "journal-article" @default.
- W2012588007 hasAuthorship W2012588007A5002538047 @default.
- W2012588007 hasAuthorship W2012588007A5014960520 @default.
- W2012588007 hasConcept C118552586 @default.
- W2012588007 hasConcept C126322002 @default.
- W2012588007 hasConcept C15744967 @default.
- W2012588007 hasConcept C169760540 @default.
- W2012588007 hasConcept C170493617 @default.
- W2012588007 hasConcept C200170125 @default.
- W2012588007 hasConcept C2775864247 @default.
- W2012588007 hasConcept C2776134451 @default.
- W2012588007 hasConcept C2777490545 @default.
- W2012588007 hasConcept C2777529043 @default.
- W2012588007 hasConcept C2779177272 @default.
- W2012588007 hasConcept C2779583969 @default.
- W2012588007 hasConcept C2780092697 @default.
- W2012588007 hasConcept C2910584757 @default.
- W2012588007 hasConcept C31487548 @default.
- W2012588007 hasConcept C37000724 @default.
- W2012588007 hasConcept C558461103 @default.
- W2012588007 hasConcept C71924100 @default.
- W2012588007 hasConcept C8439214 @default.
- W2012588007 hasConcept C98274493 @default.
- W2012588007 hasConceptScore W2012588007C118552586 @default.
- W2012588007 hasConceptScore W2012588007C126322002 @default.
- W2012588007 hasConceptScore W2012588007C15744967 @default.
- W2012588007 hasConceptScore W2012588007C169760540 @default.
- W2012588007 hasConceptScore W2012588007C170493617 @default.
- W2012588007 hasConceptScore W2012588007C200170125 @default.
- W2012588007 hasConceptScore W2012588007C2775864247 @default.
- W2012588007 hasConceptScore W2012588007C2776134451 @default.
- W2012588007 hasConceptScore W2012588007C2777490545 @default.
- W2012588007 hasConceptScore W2012588007C2777529043 @default.
- W2012588007 hasConceptScore W2012588007C2779177272 @default.
- W2012588007 hasConceptScore W2012588007C2779583969 @default.
- W2012588007 hasConceptScore W2012588007C2780092697 @default.
- W2012588007 hasConceptScore W2012588007C2910584757 @default.
- W2012588007 hasConceptScore W2012588007C31487548 @default.
- W2012588007 hasConceptScore W2012588007C37000724 @default.
- W2012588007 hasConceptScore W2012588007C558461103 @default.
- W2012588007 hasConceptScore W2012588007C71924100 @default.
- W2012588007 hasConceptScore W2012588007C8439214 @default.
- W2012588007 hasConceptScore W2012588007C98274493 @default.
- W2012588007 hasIssue "sup2" @default.
- W2012588007 hasLocation W20125880071 @default.
- W2012588007 hasLocation W20125880072 @default.
- W2012588007 hasOpenAccess W2012588007 @default.
- W2012588007 hasPrimaryLocation W20125880071 @default.
- W2012588007 hasRelatedWork W1512765671 @default.
- W2012588007 hasRelatedWork W2012588007 @default.
- W2012588007 hasRelatedWork W2021185951 @default.
- W2012588007 hasRelatedWork W2029024244 @default.
- W2012588007 hasRelatedWork W2056255984 @default.
- W2012588007 hasRelatedWork W2121809100 @default.
- W2012588007 hasRelatedWork W2323278306 @default.
- W2012588007 hasRelatedWork W2736317006 @default.
- W2012588007 hasRelatedWork W2747729460 @default.
- W2012588007 hasRelatedWork W4283362117 @default.
- W2012588007 hasVolume "11" @default.